Novo Nordisk Launches Safe Pharmaceuticals Disposal Initiative for Employees
Novo Nordisk Global Business Services launches safe pharmaceuticals disposal initiative for employees
Overview
Novo Nordisk Global Business Services (GBS) announced the launch of a sustainable initiative called Eco Med Safe aimed at promoting safe and responsible disposal of pharmaceutical products, on World Patient Safety Day, observed on September 17 in partnership with Connect and Heal Foundation.
About the Programme
- Launched internally for employees, the programme is designed to minimise environmental impact and enhance public health by safely disposing unused or expired medicines.
- The comprehensive eco-pharmacovigilance initiative is a pivotal step towards Novo Nordisk’s commitment to minimise environmental impact and maximise our positive impact on public health.
Novo Nordisk Statement on The Programme
Through this programme, we aim to address the significant environmental risks posed by improper disposal of medications. The safe removal of expired or unused pharmaceuticals prevents contamination of water systems and soil, protecting both ecosystems, human and animal health. This initiative is also likely to contribute to mitigating the development of antibiotic-resistant bacteria which is a growing global concern linked to the presence of antibiotics in the environment,” stated Dr. Prasanna Kumar T S, vice president, global safety, Novo Nordisk Global Business Services.
From MD: Novo Nordisk Global Business Services
- Building on our Circular for Zero environmental strategy, we view the Sustainable Development Goals representing good health & sustainable communities as a great opportunity to enhance our sustainability efforts. The Eco Med Safe program presents an innovative educational platform, promoting responsible medication disposal practices and significantly reducing environmental risks.”
- Education is essential for achieving success in this endeavour, and we are enthusiastic about partnering with other companies and the broader healthcare community. Together, we can better understand the impacts of improper disposal of unused medicines and support voluntary community collection programs,"" said John Dawber, corporate vice president & managing director, Novo Nordisk Global Business Services.
